|
TMEM20 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.382590E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.554000E-01 |
| Normal-vs-Stage2 |
9.447200E-01 |
| Normal-vs-Stage3 |
8.126200E-02 |
| Normal-vs-Stage4 |
1.468040E-02 |
| Stage1-vs-Stage2 |
4.623000E-01 |
| Stage1-vs-Stage3 |
2.432200E-01 |
| Stage1-vs-Stage4 |
2.812500E-02 |
| Stage2-vs-Stage3 |
2.218200E-01 |
| Stage2-vs-Stage4 |
9.500200E-02 |
| Stage3-vs-Stage4 |
4.151400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.513450E-01 |
| Normal-vs-AfricanAmerican |
2.198400E-01 |
| Normal-vs-Asian |
1.635610E-02 |
| Caucasian-vs-AfricanAmerican |
6.982000E-01 |
| Caucasian-vs-Asian |
2.703400E-01 |
| AfricanAmerican-vs-Asian |
1.646350E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.503000E-01 |
| Normal-vs-Female |
7.151800E-02 |
| Male-vs-Female |
1.889640E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.268100E-02 |
| Normal-vs-Age(41-60Yrs) |
2.701800E-01 |
| Normal-vs-Age(61-80Yrs) |
1.743990E-01 |
| Normal-vs-Age(81-100Yrs) |
6.095600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.119800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.609600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.535200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.806600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.198750E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.964230E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.602000E-01 |
| Normal-vs-Grade 2 |
2.844800E-01 |
| Normal-vs-Grade 3 |
8.146400E-02 |
| Normal-vs-Grade 4 |
6.890100E-02 |
| Grade 1-vs-Grade 2 |
4.180800E-01 |
| Grade 1-vs-Grade 3 |
1.985200E-01 |
| Grade 1-vs-Grade 4 |
1.424020E-01 |
| Grade 2-vs-Grade 3 |
5.619800E-01 |
| Grade 2-vs-Grade 4 |
3.210200E-01 |
| Grade 3-vs-Grade 4 |
5.531800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.893000E-01 |
| Normal-vs-ccB subtype |
2.848400E-01 |
| ccA subtype-vs-ccB subtype |
3.960800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.498570E-01 |
| Normal-vs-N1 |
3.363800E-01 |
| N0-vs-N1 |
7.610800E-01 |
|
|
